Atlas Trials

Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects

Clinical trial NCT02045849 · COMPLETED

Trial details

NCT number
NCT02045849
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Infections, Bacterial
Start date
2014-01-28
Primary completion
2014-08-21
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.